Phase II trial of (177)lutetium radiolabeled anti-PSMA antibody J591 ((177)Lu-J591) for metastatic castrate-resistant prostate cancer (metCRPC): Survival update and expansion cohort with biomarkers Meeting Abstract
| Authors: | Tagawa, S. T.; Akhtar, N. H.; Osborne, J.; Christos, P. J.; Vallabhajosula, S.; Goldsmith, S. J.; Kahn, R.; Ecker, C.; Beltran, H.; Morris, M. J.; Milowsky, M. I.; Bander, N. H.; Nanus, D. M. |
| Abstract Title: | Phase II trial of (177)lutetium radiolabeled anti-PSMA antibody J591 ((177)Lu-J591) for metastatic castrate-resistant prostate cancer (metCRPC): Survival update and expansion cohort with biomarkers |
| Meeting Title: | 2013 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2013 Feb 14-16 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-02-20 |
| Language: | English |
| ACCESSION: | WOS:000333679600122 |
| DOI: | 10.1200/jco.2013.31.6_suppl.121 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 121 -- Source: Wos |
